218 related articles for article (PubMed ID: 6870278)
1. Tissue locations for the turnover of radioactively labeled rat orosomucoid in vivo.
Kuranda MJ; Aronson NN
Arch Biochem Biophys; 1983 Jul; 224(2):526-33. PubMed ID: 6870278
[TBL] [Abstract][Full Text] [Related]
2. Use of active site-directed inhibitors to study in situ degradation of glycoproteins by the perfused rat liver.
Kuranda MJ; Aronson NN
J Biol Chem; 1985 Feb; 260(3):1858-66. PubMed ID: 3918044
[TBL] [Abstract][Full Text] [Related]
3. Degradation of [6-3H]- and [1-14C]glucosamine-labeled asialo-alpha 1-acid glycoprotein by the perfused rat liver.
Aronson NN; Docherty PA
J Biol Chem; 1983 Apr; 258(7):4266-71. PubMed ID: 6833257
[TBL] [Abstract][Full Text] [Related]
4. Uptake and degradation of 125I-labeled rat asialoorosomucoid by the perfused rat liver.
Dennis PA; Aronson NN
Biochim Biophys Acta; 1984 Mar; 798(1):14-20. PubMed ID: 6704419
[TBL] [Abstract][Full Text] [Related]
5. Biliary excretion of FITC metabolites after administration of FITC labeled asialo orosomucoid as a measure of lysosomal proteolysis.
van der Sluijs P; Oosting R; Weitering JG; Hardonk MJ; Meijer DK
Biochem Pharmacol; 1985 May; 34(9):1399-405. PubMed ID: 3922377
[TBL] [Abstract][Full Text] [Related]
6. Use of radioactive glucosamine in the perfused rat liver to prepare alpha 1-acid glycoprotein (orosomucoid) with 3H- or 14C-labelled sialic acid and N-acetylglucosamine residues.
Aronson NN
Biochem J; 1982 Apr; 203(1):141-8. PubMed ID: 7103933
[TBL] [Abstract][Full Text] [Related]
7. In vivo quantification of removal of asialo-orosomucoid from the circulation in anaesthetized streptozotocin-diabetic rats.
Appel M; Potrat P; Feger J; Mas-Chamberlin C; Durand G
Diabetologia; 1986 Jun; 29(6):383-7. PubMed ID: 3743923
[TBL] [Abstract][Full Text] [Related]
8. 131I-asialo-alpha 1-acid glycoprotein. Investigation of its use for liver function tests; metabolism in the rat.
van Rijk PP; van den Hamer CJ
J Lab Clin Med; 1976 Jul; 88(1):142-50. PubMed ID: 932532
[TBL] [Abstract][Full Text] [Related]
9. Differences between fluid-phase endocytosis (pinocytosis) and receptor-mediated endocytosis in isolated rat hepatocytes.
Strømhaug PE; Berg TO; Gjøen T; Seglen PO
Eur J Cell Biol; 1997 May; 73(1):28-39. PubMed ID: 9174669
[TBL] [Abstract][Full Text] [Related]
10. In vivo quantification of receptor-mediated uptake of asialoglycoproteins by rat liver.
Pardridge WM; Van Herle AJ; Naruse RT; Fierer G; Costin A
J Biol Chem; 1983 Jan; 258(2):990-4. PubMed ID: 6185482
[TBL] [Abstract][Full Text] [Related]
11. Clearance of rat C-reactive protein in vivo and by perfused liver.
Yang C; Mookerjea S; Nagpurkar A
Glycobiology; 1992 Feb; 2(1):41-8. PubMed ID: 1550988
[TBL] [Abstract][Full Text] [Related]
12. Hepatic synthesis of carnitine from protein-bound trimethyl-lysine. Lysosomal digestion of methyl-lysine-labelled asialo-fetuin.
LaBadie J; Dunn WA; Aronson NN
Biochem J; 1976 Oct; 160(1):85-95. PubMed ID: 64247
[TBL] [Abstract][Full Text] [Related]
13. Glycoprotein catabolism in rat liver: Lysosomal digestion of iodinated asialo-fetuin.
LaBadie JH; Chapman KP; Aronson NN
Biochem J; 1975 Nov; 152(2):271-9. PubMed ID: 56934
[TBL] [Abstract][Full Text] [Related]
14. Uptake, metabolism and excretion of orally and intravenously administered, 14C- and 3H-labeled N-acetylneuraminic acid mixture in the mouse and rat.
Nöhle U; Schauer R
Hoppe Seylers Z Physiol Chem; 1981 Nov; 362(11):1495-506. PubMed ID: 7030915
[TBL] [Abstract][Full Text] [Related]
15. Uptake and degradation of asialo-orosomucoid in hepatocytes from carcinogen-treated rats.
Schwarze E; Tolleshaug H; Seglen O
Carcinogenesis; 1985 May; 6(5):777-82. PubMed ID: 4006062
[TBL] [Abstract][Full Text] [Related]
16. Effects of lysosomal inhibitors on 125I-insulin and 125I-asialofetuin degradation by the isolated, perfused rat liver and isolated rat hepatocytes.
Ward WF; Moss AL
Diabetes; 1985 May; 34(5):446-51. PubMed ID: 2580748
[TBL] [Abstract][Full Text] [Related]
17. Metabolism of HDL-cholesteryl ester in the rat, studied with a nonhydrolyzable analog, cholesteryl linoleyl ether.
Stein Y; Dabach Y; Hollander G; Halperin G; Stein O
Biochim Biophys Acta; 1983 Jun; 752(1):98-105. PubMed ID: 6849969
[TBL] [Abstract][Full Text] [Related]
18. Receptor-mediated endocytosis of ovalbumin by two carbohydrate-specific receptors in rat liver cells. The intracellular transport of ovalbumin to lysosomes is faster in liver endothelial cells than in parenchymal cells.
Kindberg GM; Magnusson S; Berg T; Smedsrød B
Biochem J; 1990 Aug; 270(1):197-203. PubMed ID: 2396980
[TBL] [Abstract][Full Text] [Related]
19. Disposition of radioactivity after injection of liver-targeted proteins labeled with 111In or 125I. Effect of labeling on distribution and excretion of radioactivity in rats.
Staud F; Nishikawa M; Morimoto K; Takakura Y; Hashida M
J Pharm Sci; 1999 Jun; 88(6):577-85. PubMed ID: 10350492
[TBL] [Abstract][Full Text] [Related]
20. 125I-glycoconjugate labels for identifying sites of protein catabolism in vivo: effect of structure and chemistry of coupling to protein on label entrapment in cells after protein degradation.
Strobel JL; Baynes JW; Thorpe SR
Arch Biochem Biophys; 1985 Aug; 240(2):635-45. PubMed ID: 2411222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
